Hair Loss in Psychopharmacology

References

• Rook A, Dawber R (eds.): Diseases of the Hair and Scalp, 2nd ed. Oxford: Blackwell; 1982
   Google Scholar
• Stroud JD: Diagnosis and management of the hair loss patient.Cutis 1987; 40(3):272–276
   Google Scholar
• Reeves JT, Maibach HI: Drug and chemical induced hair loss. In: Marzulli FN, Maibach HI, eds. Advances in Modern Toxicology, Vol. 4. Dermatotoxicology and Pharmacology. Washington: Hemisphere; 1977; 488
   Google Scholar
• Nielsen TA, Reichel M: Alopecia: Diagnosis and manage-ment. Am Family Phys 1995; 51:1513–1522
   PubMed Web of Science ®Google Scholar
• Tobin DJ, Orentreich N, Fenton DA, Bystryn JC: Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994; 102(5):721–724
   Google Scholar
• Dunagin WG: Clinical toxicity of chemotherapeutic agents: Dermatologic toxicity. Semin Oncol 1982; 9:14–22
   PubMed Web of Science ®Google Scholar
• Pillans PL, Woods DJ: Review: Drug-associated alopecia. Int J Dermatol 1995; 34:149–158
   PubMed Web of Science ®Google Scholar
• Brodin MB: Drug-related alopecia. Dermatol Clin 1987; 5(3):571–579
   Web of Science ®Google Scholar
• Picard C, Jonville-Bera AP, Billard C, Autret E: Alopecia associated with gabapentin: First case [letter]. Ann Pharma-cother 1997; 31(10):1260
   Google Scholar
• Lampl Y, Gillad R, Savira-Pinchas I, Barak T: Hair loss—An adverse reaction to treatment with vigabatrin. Acta Ther 1996; 22:51–55
   Google Scholar
• 1999 Physicians' Desk Reference, 53rd ed. Montvale, NJ: Medical Economics; 1999
   Google Scholar
• Srebrnik A, Hes JP, Brenner S: Adverse cutaneous reactions to psychotropic drugs. Act Derm Venereol (Stokh) 1991; 71(Suppl 158):3–12
   Google Scholar
• Sarantidis D, Waters B: A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry 1983; 143:42–50
   PubMedGoogle Scholar
• Orwin A: Hair loss following lithium therapy. Br J Dermatol 1983; 108:503–504
   PubMed Web of Science ®Google Scholar
• McCreadie RG, Morrison DP: The impact of lithium in South West Scotland: Demographic and clinical findings. Br J Psychi-atry 1985; 146:70–74
   PubMed Web of Science ®Google Scholar
• Jefferson JW, Greist JH, Diamond RL: Lithium and hair loss. Int Drug Ther Newsl 1979; 14:23
   Google Scholar
• Yassa R, Ananth J: Hair loss in the course of lithium treat-ment: A report of 2 cases. Can J Psychiatry 1983; 28:132–133
   PubMed Web of Science ®Google Scholar
• Mortimer PS, Dawber RP: Hair loss and lithium. mt. Derma-tol 1984; 23:603–604
   Google Scholar
• Vestergaard P, Amdisen A, Schou M: Clinically significant side effects of lithium treatment: A survey in long-term treat-ment. Acta Psychiatr Scand 1980; 62:193–200
   PubMed Web of Science ®Google Scholar
• Silvestri A, Santonastaso P, Paggiarin D: Alopecia areata during lithium therapy. Gen Hosp Psychiatry 1988: 10:46–48
   PubMed Web of Science ®Google Scholar
• Bork K: Undesirable drug reactions affecting the hair and nails. In: Bork K, ed. Cutaneous Side Effects of Drugs. Phila-delphia: Saunders; 1988: 249
   Google Scholar
• Kirov G: Thyroid disorders in lithium-treated patients. J Af-fect Disord 1998; 50(433–40
   Google Scholar
• Ramanathan M, Abidin MN, Muthukumarappan M: The prevalence of skin manifestations in thyrotoxicosis-A retro-spective study. Med J Malaysia 1989; 44(4):324–328
   Google Scholar
• Freinkel RK, Freinkel N: Hair growth and alopecia in hypo-thyroidism. Arch Dermatol 1972; 106(3):349–352
   Google Scholar
• Signore RI, von Weiss J. Alopecia of myxedema: Clinical response to levothyroxine sodium. J Am Acad Dermatol 1991; 25(5 Pt 2):902–904
   Google Scholar
• Dawber RP, Mortimer PS: Hair loss during lithium treatment. Br J Dermatol 1982; 107:124–125
   PubMed Web of Science ®Google Scholar
• Kusumi Y: A cutaneous side effect of lithium. Dis Nerv Syst 1971; 32:853–854
   PubMedGoogle Scholar
• Muniz CE, Salem RB, Director KL: Hair loss in a patient receiving lithium. Psychosomatics 1982; 23(3):312–313
   Google Scholar
• Eustace DP: Lithium-induced reaction. Br J Psychiatry 1986; 148:752
   Google Scholar
• Ghadirian AM, Lalinec-Michaud M: Report of a patient with lithium-related alopecia and psoriasis. J Clin Psychiatry 1986; 47(4):212–213
   Google Scholar
• Wagner KD, Teicher MH: Lithium and hair loss in childhood. Psychosomatics 1991; 32(3):355–356
   Google Scholar
• Davis R, Peters DH, McTavish D: Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epi-lepsy. Drugs 1994; 47(2):332–372
   Google Scholar
• McKinney PA, Finkenbine RD, deVane LC: Alopecia and mood stabilizer therapy. Ann Clin Psychiatry 1996; 8:183–185
   PubMedGoogle Scholar
• Klotz U. Schweizer C: Valproic acid in childhood epilepsy: Anticonvulsive efficacy in relation to plasma levels. lot J Clin Pharmacol 1980; 18(10):461–465
   Google Scholar
• Despland PA: Tolerance to and unwanted effects of valproate sodium. Schweiz Rundschau Med Praxis 1994; 83(40): 1132–1139
   Google Scholar
• Henriksen O, Johannessen SI: Clinical and pharmacokinetic observations on sodium valproate-A 5-year follow-up study in 100 children with epilepsy. Acta Neurol Scand 1982; 65(5):504–523
   Google Scholar
• Beydoun A. Sackellares JC, Shu V: Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: A double-blind, concentration-response design clinical trial. Neurology 1997; 48:182–188
   Google Scholar
• Uehlinger C, Barrelet L, Touabi M, Baumann P: Alopecia and mood stabilizers: Two case reports. Eur Arch Psychiatry Clin Neurosci 1992; 242:85–88
   PubMedGoogle Scholar
• Zaccara G, Campostrini R, Paganini M, Messori A, Valenza T, Arnetoli G, Zappoli R: Long-term treatment with sodium valproate: Monitoring of venous ammonia concentrations and adverse effects. Ther Drug Monitoring 1987; 9(1):34–40
   Google Scholar
• Fatemi SH, Calabrese JR: Treatment of valproate-induced alopecia. Ann Pharmacother 1995; 29(12):1302
   Google Scholar
• Healy MA, Aslam MA: The clinical significance of metal binding in convulsion control with sodium valproate. J Clin Hosp Pharmacy 1986; 11:189–198
   Google Scholar
• Tasaki M, Hanada K, Hashimoto I: Analyses of serum copper and zinc levels and copper/zinc ratios in skin diseases. J Der-matol 1993; 20(1):21–24
   Google Scholar
• Hurd RW, Van Rinsvelt HA, Wilder BJ, Karas B, Maenhaut W, De Reu L: Selenium, zinc, and copper changes in valproic acid: Possible relation to drug side effects. Neurology 1984; 34(10):1393–1395
   Google Scholar
• Sozuer DT, Barutcu UB, Karakoc Y, Yalcin E, Onen S: The effects of antiepileptic drugs on serum zinc and copper levels in children. J Basic Clin Physiol Pharmacol 1995; 6:265–269
   PubMedGoogle Scholar
• Kaji M, Ito M, Okuno T, Momoi T, Sasaki H, Yamanaka C, Yorifuji T, Mikawa H: Serum copper and zinc levels in epilep-tic children with valproate treatment. 1992; Epilepsia 33(3):555–557
   Google Scholar
• Suzuki T, Koizumi J, Moroji T, Shiraishi H, Hon i T, Baba A,Kawai N, Tada K: Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epilep-tics. Biol Psychiatric 1992; 31:571–581
   PubMed Web of Science ®Google Scholar
• Kuzuya T, Hasegawa T, Shimizu K, Nabeshima T: Effect of anti-epileptic drugs on serum zinc and copper concentrations in epileptic patients. Int J Clin Pharmacol Ther Toxicol 1993; 31(2):61–65
   PubMedGoogle Scholar
• Covanis A, Gupta AK, Jeavons PM: Sodium valproate: Mo-notherapy and polytherapy. Epilepsia 1982; 23(6):693–720
   PubMed Web of Science ®Google Scholar
• Bittencourt PR: Valproic acid, curly hair and weight gain. Arq Neuro-Psiquiatria 1986; 44(1):78–81
   Google Scholar
• Jeavons PM, Clark JE, Harding GE: Valproate and curly hair [letter]. Lancet 1997; 1(8007):359
   Google Scholar
• Mathew NT, Ali S: Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 1991; 31(2):71–74
   Google Scholar
• Herranz JL. Arteaga R, Armijo JA: Change in hair colour induced by valproic acid. Dev Med Child Neurol 1981; 23(3):386–387
   Google Scholar
• Gupta AK: "Perming" effect associated with chronic val-proate therapy. Br J Clin Pract 1988; 42(2):75–77
   Google Scholar
• Verity CM, Hosking G, Easter DJ: A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. Dev Med Child Neurol 1995; 37(2):97–108
   PubMedGoogle Scholar
• Mattson RH, Cramer JA, Collins JF: A comparison of val-proate with carbamazepine for the treatment of complex par-tial seizures and secondarily generalized tonic-donic seizures in adults. N Engl J Med 1992; 327:765–771
   PubMed Web of Science ®Google Scholar
• Shuper A, Stahl B, Weitz R: Carbamazepine-induced hair loss. Drug Intel' Clin Pharm 1985; 19:924–925
   Google Scholar
• Hilder RJ: Propranolol and alopecia. Cutis 1979; 24(1):63–64
   Google Scholar
• Martin CM, Southwick EG, Maibach HI: Propranolol induced alopecia. Am Heart J 1973; 86:236
   PubMed Web of Science ®Google Scholar
• Scribner MD: Propranolol treatment. Arch Dermatol 1977; 113:1303
   Google Scholar
• England JR, England JD: Alopecia and propranolol therapy. A ust Fain Physician 1982; 11(3):225–226
   Google Scholar
• Ikeda A. Shibasaki H, Shiozaki A, Kimura J: Alopecia with carbamazepine in two patients with focal seizures. J Neurol Neurosurg Psychiatry 1997; 63(4):549–550
   Google Scholar
• Warnock JK, Sieg K, Willsie D, Stevenson EK: Drug-related alopecia in patients treated with tricyclic antidepressants. J Nerv Ment Dis 1991; 179(7):441–442
   Google Scholar
• Baral J, Deakins S: Imipramine-induced alopecia areata-like lesions. Int J Dermatol 1987; 26(3):198
   Google Scholar
• Friedman M. Iatrogenic alopecia: J Fam Pract 1994; 39(2):114
   Google Scholar
• Perini G, Zara M, Cipriani R, Carraro C, Preti A, Gava F, Coghi P, Peserico A: Imipramine in alopecia areata. A double-blind, placebo-controlled study. Psychother Psychosom 1994; 61(3-4):195–198
   PubMedGoogle Scholar
• Mareth TR: Hair loss associated with fluoxetine use in two family members. J Clin Psychiatry 1994; 55(4):163
   Google Scholar
• Rapaport M, Coccaro E, Sheline Y, Perse T, Holland P, Fabre L, Bradford D: A comparison of fluvoxamine and fluoxetine in the treatment of major depression. J Clin Psychopharmacol 1996; 16(5):373–378
   PubMedGoogle Scholar
• Seifritz E, Hatzinger M, Muller MJ, Hemmeter U, Trachsler-Holsboer E: Hair loss associated with fluoxetine but not with citalopram. Can J Psychiatry 1995; 40(6):362
   Google Scholar
• Ananth J, Elinishaugh A: Hair loss associated with fluoxetine treatment. Can J Psychiatry 1991; 36(8):621
   Google Scholar
• McDougle CJ, Brodkin ES, Naylor ST, Carlson DC, Cohen DJ, Price LH: Sertraline in adults with pervasive develop-mental disorders: A prospective open-label investigation. J Clin Psychopharmacol 1998; 18(1):62–66
   PubMed Web of Science ®Google Scholar
• Bourgeois J: Two cases of hair loss after sertraline use. J Clin Psychopharmacol 1996; 16(1):91–92
   Web of Science ®Google Scholar
• Jenike MA: Severe hair loss associated with fluoxetine use. Am J Psych 1991; 148:392
   Web of Science ®Google Scholar
• Ogilvie AD: Hair loss during fluoxetine treatment. Lancet 1993; 342(8884):1423
   Web of Science ®Google Scholar
• Gupta S, Major LF: Hair loss associated with fluoxetine. Br J Psychiatry 1991; 159:737–738
   Google Scholar
• Bhatara VS, Gupta S, Freeman JW: Fluoxetine-associated paresthesias and alopecia in a woman who tolerated sertraline. J Clin Psychiatry 1996; 57:5
   Google Scholar
• Parameshwar E: Hair loss associated with fluvoxamine use. Am J Psychiatry 1996; 153(4):581–582
   Google Scholar
• Gupta S, Gilroy, Jr. WR: Hair loss associated with nefazodone. J Fam Pract 1997; 44(I):20–21
   Google Scholar
• Rauch SL, O'Sullivan RL, Jenike MA: Open treatment of obsessive-compulsive disorder with venlafaxine: A series of ten cases. J Clin Psychopharmacol 1996; 16:81–84
   PubMed Web of Science ®Google Scholar
• Kubota T, Ishikura T, Jibiki I: Alopecia areata associated with haloperidol. Jpn J Psychiatry Neurol 1994; 48(3):579–581
   Google Scholar
• Alexander S: Diffuse alopecia in women. Trans Annu Rep St. Johns Hosp Dermatol Soc 1965; 51:99
   Google Scholar
• Eckert J, Church RE, Ebling FJ, Munro DS: Hair loss in women. Br J Dermatol 1967; 79:543
   PubMed Web of Science ®Google Scholar